CXCR6 and breast cancer: Western analysis show that cells treated with CXCL16 at different time points, both E-cadherin and vimentin are no significant changes (Supplementary Figure 3), suggesting that CXCL16/CXCR6 signaling is irresponsible for EMT, potentially involved in BC invasion.